Security
Verve Therapeutics Inc. Common Stock · VERV
VERVNASDAQCommon stockHistorical · closed Jul 25, 2025CIK 1840574Updated Nov 16, 2026
VERV price & chart
Historical security
This listing closed Jul 25, 2025. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 647,392,000Source | 752,688,000Source | 679,223,000Source | 384,124,000Source |
| Property, Plant and Equipment, NetUSD | 18,644,000Source | 22,505,000Source | 18,778,000Source | 7,224,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 172,560,000Source | 206,180,000Source | 115,412,000Source | 64,330,000Source |
| Assets, CurrentUSD | 542,751,000Source | 637,949,000Source | 563,159,000Source | 367,128,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 15,215,000Source | 8,102,000Source | 7,339,000Source | 6,686,000Source |
| Operating Lease, Right-of-Use AssetUSD | 78,082,000Source | 85,295,000Source | 91,877,000Source | 1,839,000Source |
| Other Assets, NoncurrentUSD | 3,141,000Source | 2,165,000Source | 585,000Source | 2,696,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 153,992,000Source | 153,186,000Source | 128,291,000Source | 26,772,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | — |
| Common Stock, Value, IssuedUSD | 89,000Source | 82,000Source | 62,000Source | 49,000Source |
| Retained Earnings (Accumulated Deficit)USD | -743,014,000Source | -544,305,000Source | -344,237,000Source | -186,850,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 428,000Source | 272,000Source | -694,000Source | -228,000Source |
| Stockholders' Equity Attributable to ParentUSD | 493,400,000Source | 599,502,000Source | 550,932,000Source | 357,352,000Source |
| Additional Paid in Capital, Common StockUSD | 1,235,897,000Source | 1,143,453,000Source | 895,801,000Source | 544,381,000Source |
| Liabilities and EquityUSD | 647,392,000Source | 752,688,000Source | 679,223,000Source | 384,124,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 42,909,000Source | 37,006,000Source | 35,095,000Source | 22,024,000Source |
| Operating Lease, Liability, CurrentUSD | 10,442,000Source | 10,192,000Source | 11,904,000Source | 1,955,000Source |
| Accounts Payable, CurrentUSD | 4,520,000Source | 6,636,000Source | 2,424,000Source | 7,077,000Source |
| Operating Lease, Liability, NoncurrentUSD | 59,541,000Source | 64,715,000Source | 70,014,000Source | — |
| Other Liabilities, NoncurrentUSD | 95,000Source | 189,000Source | 283,000Source | 377,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 24,342,000Source | 20,178,000Source | 20,767,000Source | 12,992,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 524,300,000Source | 624,000,000Source | 554,800,000Source | — |
| Deferred Revenue, CurrentUSD | 3,605,000Source | — | — | — |
| Deferred Tax Liabilities, NetUSD | 22,400,000Source | 24,461,000Source | 25,875,000Source | 1,400,000Source |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -198,709,000Source | -200,068,000Source | -157,387,000Source | -120,314,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 43,255,000Source | 35,116,000Source | 22,477,000Source | 7,072,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | -1,830,000Source | 3,910,000Source | -5,216,000Source | 6,829,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -157,692,000Source | -149,549,000Source | -122,332,000Source | -77,880,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 74,876,000Source | 27,690,000Source | -155,955,000Source | -239,098,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 3,736,000Source | 9,283,000Source | 13,232,000Source | 4,359,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 49,196,000Source | 212,577,000Source | 328,956,000Source | 377,089,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -33,620,000Source | 90,718,000Source | 50,669,000Source | 60,111,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 177,334,000Source | 210,954,000Source | 120,236,000Source | 69,567,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 43,255,000Source | 35,116,000Source | 22,477,000Source | 7,072,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 524,300,000Source | 624,000,000Source | 554,800,000Source | — |
| DepreciationUSD | 6,753,000Source | 5,455,000Source | 2,804,000Source | 1,500,000Source |
| General and Administrative ExpenseUSD | 56,645,000Source | 49,936,000Source | 37,533,000Source | 18,865,000Source |
| Income Tax Expense (Benefit)USD | 349,000Source | 275,000Source | 53,000Source | — |
| Marketable Securities, Unrealized Gain (Loss)USD | 100,000Source | 100,000Source | 800,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | -198,709,000Source | -200,068,000Source | -157,387,000Source | -120,314,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -198,709,000Source | -200,068,000Source | -157,387,000Source | -120,314,000Source |
| Nonoperating Income (Expense)USD | 30,300,000Source | 23,331,000Source | 8,353,000Source | -33,247,000Source |
| Operating ExpensesUSD | 260,992,000Source | 234,882,000Source | 167,628,000Source | 87,067,000Source |
| Other Nonoperating Income (Expense)USD | 28,762,000Source | 23,166,000Source | 6,867,000Source | 142,000Source |
| Proceeds from Contributed CapitalUSD | — | — | — | 0Source |
| Proceeds from Issuance of Common StockUSD | 0Source | 31,710,000Source | 39,986,000Source | — |
| Proceeds from Stock Options ExercisedUSD | 1,260,000Source | 1,200,000Source | 2,175,000Source | 966,000Source |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -228,660,000Source | -223,124,000Source | -165,687,000Source | -87,067,000Source |
| Other Nonoperating Income (Expense)USD | 28,762,000Source | 23,166,000Source | 6,867,000Source | 142,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -198,360,000Source | -199,793,000Source | -157,334,000Source | — |
| Income Tax Expense (Benefit)USD | 349,000Source | 275,000Source | 53,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | -198,709,000Source | -200,068,000Source | -157,387,000Source | -120,314,000Source |
| Earnings Per Share, BasicUSD per share | -2.35Source | -3.12Source | -2.91Source | — |
| Earnings Per Share, DilutedUSD per share | -2.35Source | -3.12Source | -2.91Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 84,722,277Source | 64,175,137Source | 54,023,653Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 84,722,277Source | 64,175,137Source | 54,023,653Source | — |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 349,000Source | 275,000Source | 53,000Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | 6,753,000Source | 5,455,000Source | 2,804,000Source | 1,535,000Source |
| General and Administrative ExpenseUSD | 56,645,000Source | 49,936,000Source | 37,533,000Source | 18,865,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 198,400,000Source | 199,800,000Source | 157,400,000Source | 120,300,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -198,709,000Source | -200,068,000Source | -157,387,000Source | -120,314,000Source |
| Nonoperating Income (Expense)USD | 30,300,000Source | 23,331,000Source | 8,353,000Source | -33,247,000Source |
| Operating ExpensesUSD | 260,992,000Source | 234,882,000Source | 167,628,000Source | 87,067,000Source |
| Research and Development ExpenseUSD | 204,347,000Source | 184,946,000Source | 130,095,000Source | 68,202,000Source |